XTRA:FMEHealthcare
A Look At Fresenius Medical Care (XTRA:FME) Valuation After Mixed Q1 2026 Results And €1b Share Buyback
Fresenius Medical Care (XTRA:FME) is back in focus after first quarter 2026 earnings showed mixed results, alongside confirmation of flat full year guidance and completion of a €1b share buyback representing about 8.5% of share capital.
See our latest analysis for Fresenius Medical Care.
Despite the 3.82% 1 day share price return taking the stock to €37.2, Fresenius Medical Care’s 30 day share price return of 4.88% and 1 year total shareholder return of 23.41% point to fading momentum...